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Results: Figure 1 displays the mean differences of the dose 
metrics between repeated CT and CBCT, for Varian and 
Elekta CBCT scans. For Varian, a good agreement between 
the dose distributions recalculated on CBCT and repeated CT 
was observed when a thorax-specific HU-ED table was used. 
For Elekta, the dose metrics showed larger deviations with 
the thorax-specific HU-ED table, however, using a patient-
specific HU-ED table resulted in similar accuracy as for Varian 
CBCT dose calculations. Differences between repeated CT 
and CBCT dose metrics were below 3% for both vendors.  
 
 
Conclusion: Differences between Elekta and Varian CBCT, 
including hardware, reconstruction software, HU calibration, 
FOV and scan length, resulted in different challenges for 
CBCT dose calculations for the different vendors. For Elekta 
CBCT scans, the procedure with a patient-specific HU-ED 
table resulted in similar accuracy as for Varian CBCT dose 
calculations with a general HU-ED correction for all thorax 
patients, but is more time-consuming. The vendor-specific 
corrective methods used in this study, resulted in dose 
calculations feasible for treatment re-evaluation for both 
Elekta and Varian CBCT scans. 
References: 1.Yang et al. PhysMedBiol 2007, 2.Richter et al. 
RadOnc 2008, 3. Hatton et al. PhysMedBiol 2009, 4.Fotina et 
al. RadiotherOnc 2012, 5. Dunlop et al. StrahlentherOnkol 
2015 
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Purpose or Objective: At our department, patients with cT1-
2aN0M0 laryngeal cancer are treated with volumetric-
modulated arc therapy (VMAT). The treatment plan quality is 
monitored by plan evaluations on weekly repeat CTs. The 
purpose of this study was to determine plan quality during 
treatment by recalculating the actually given dose based on 
repeat CT.  
 
Material and Methods: Three patients treated with 
accelerated radiotherapy (66-70 Gy in 2 Gy fractions) were 
selected because of over dosages exceeding 78 Gy at the 
transition from air to tissue. Each clinical VMAT plan (plan I) 
was optimized towards homogeneous dose distributions in the 
planning target volumes (PTV) and low as possible dose to the 
critical organs such as the swallowing organs at risk. The 
treatment plan quality was evaluated using weekly repeat 
CTs. In addition, two more treatment plans were made 
including a density override of 0.5 g.cm-3 for the PTV-in-air 
overlap region (plan II), and the PTV-in-air + 5 mm region 
(plan III). All plans were evaluated with the PTV-in-air region 
assigned a density override value of 0.0 and 1.0 g.cm-3 to 
simulate the initial planning scenario and to simulate 
extension of CTV-in-air, resp. Finally, the “actual given dose” 
of the clinical target volume (CTV) was estimated by 
accumulated repeat CT dose evaluations. 
 
Results: The repeat CTs showed an extending CTV towards 
the laryngeal air cavity over the course of treatment. Repeat 
CT evaluations indicated increasing max doses up to 80 Gy. 
Evaluation of plan I on the initial planning CT, using a density 
override of 1.0 g.cm-3, showed a potential dose hotspot with 
similar max dose values (80-87 Gy). When no density override 
was assigned the PTV (D98%) coverage of plan I was 
sufficient. In contrast, plan II and III showed slightly to 
moderate PTV under dosage (65 Gy), albeit within the PTV-
in-air region. However, the accumulated CTV dose (D100) 
demonstrated no clinically relevant under dosage in the CTV 
(methods plan II: 67.4 Gy and plan III 65.2 Gy). Furthermore, 
the plan optimization approach as used in plan II and III 
resulted in reduced and acceptable max dose values within 
the targets (76.9 Gy and 74.3 Gy, resp).  
 
Conclusion: Unacceptable high doses of up to 80 Gy were 
observed in VMAT plan evaluations based on weekly repeat 
CTs. To avoid these over dosages, high fluence profiles in 
PTV-in-air regions should be avoided during planning 
optimization. An alternative VMAT optimization and 
evaluation approach has been proposed for cT1-2aN0M0 
laryngeal cancer patients. 
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Purpose or Objective: At the Leeds Cancer Centre 
approximately 40% of lung patients receiving VMAT 
radiotherapy (RT) display a reduction in tumour volume when 
imaged using CBCT during treatment. The aim of this work 
was to develop a method to assess whether the dosimetric 
impact of observed anatomical changes is sufficiently 
significant to justify a treatment replan. 
 
Material and Methods: Twelve lung patients receiving FFF 
VMAT RT planned on the Monaco 3.3 treatment planning 
system (Elekta) were identified. All had been rescanned, 
recontoured and replanned due to noted tumour shrinkage. 
For lung replans the clinical aim is to continue treating the 
original target volumes, so a rigid registration was performed 
between the planning CT and the rescan CT using a mutual 
information algorithm. Target volumes and OAR were 
transferred from the planning CT to the rescan CT and 
assessed by a physicist and clinician team to ensure they 
were clinically appropriate. The original plan was 
recalculated on the rescan CT studyset and dose volume 
histogram (DVH) statistics calculated for targets and OARs on 
the rescan studyset. 
 
Results: For patients who displayed tumour changes without 
other significant internal changes the transferred target 
structures were deemed clinically acceptable with minor 
editing. Comparison of the transferred structures to the 
replan structures indicated that differences in remarking the 
targets were larger than image registration and transferral 
errors. Small variations in spinal cord and lung contours 
suggest that it is more accurate to re-contour these 
structures on the rescan CT, especially if they are receiving a 
dose close to tolerance. This method of adaptive planning 
was found to significantly reduce the replanning time. A 
notable limitation of the process was observed for patients 
who display other significant internal anatomical changes 
such as a change in lung volume or mediastina position, 
resulting in inaccurate transferred structures. Based on the 
DVH statistics for the transferred targets and re-contoured 
OAR, 9/12 plans required a full treatment replan. Although 
the target coverage was clinically acceptable the loss of 
tumour tissue meant that nearby OAR received doses above 
their tolerance. 
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Conclusion: A method has been developed to assist the 
adaptive planning process for lung patients receiving FFF 
VMAT radiotherapy. This provides a means of assessing the 
dosimetric effect of tumour changes to determine whether a 
new treatment plan is necessary. It showed that for 25% of 
patients who received full treatment replans no replan was 
necessary, as the dosimetric effect of tumour shrinkage was 
insignificant in terms of both target coverage and OAR doses. 
Therefore it allows significant time savings in the treatment 
replanning process. Use of the technique is limited to 
patients who display tumour volume changes with no other 
significant changes to internal/external anatomy. 
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Purpose or Objective: The Gamma Knife Icon (Elekta AB, 
Schweden) allows frameless treatment of patients in a 
precise stereotactic environment using a combination of 
cone-beam computer tomography (CBCT) for positioning, a 
thermoplastic mask system for positioning and fixation and an 
infrared based camera system “high definition motion 
management” (HDMM) for patient tracking during treatment. 
Using these novel options, the Gamma Knife Icon provides the 
possibility for adaptive fractionated stereotactic 
radiotherapy (a-gkFSRT). Here we report the treatment of 
the first patient with a-gkFSRT. 
 
Material and Methods: The first patient treated with Gamma 
Knife Icon at the University Medical Center Mannheim 
received MR imaging with an individual cushion for pre-
planning with the treatment planning system (TPS) 
GammaPlan 11.0.1 (Elekta AB, Schweden) 7 days before 
treatment. For every fraction of the treatment a daily CBCT 
was performed to verify the actual scull/tumour position. An 
automatic co-registration was performed to determine the 
daily shift in translation and rotation. The TPS adapted 
automatically the shot positions to the daily position and 
recalculated the dose distribution (online adaptive planning). 
During the treatment the HDMM system recorded the intra-
fractional patient motion. Further we recorded the times for 
positioning, image guidance and treatment to define a 
clinical treatment slot. 
 
Results: The total treatment time for fraction 2-5 was around 
20 minutes. The positioning of the patient needed 0.8 min, 
CBCT positioning plus acquisition 1.03 min plus 0.62 min, CT 
data processing and adaptive planning 2.66 min and 
treatment 15.6 minutes. The mean values and standard 
deviations for the 5 daily CBCTs compared to the reference 
scan are for rotation -0.59°±0.49/0.18±0.20/0.05°±0.36 and 
for translation are 0.94mm±0.52/-0.08mm±0.08/-
1.13mm±0.89. The adaptive re-planning (duration 1.25 
minutes) every day was very accurate and yielded quality 
measures e.g. coverage, selectivity and gradient for the 
delivered dose identical regarding to the initial values. Using 
the HDMM system over all fractions we saw an intra-fractional 
movement of 0.13±0.04mm. The intra-fractional movement 
was controlled by the HDMM system and showed similar 
results as a repeated CBCT after treatment (<0.32° and 
0.20mm). 
 
Conclusion: The Gamma Knife Icon allows combining the 
accuracy of the stereotactic Gamma Knife system with the 
flexibility of fractionated treatment of a linear accelerator 
with mask system and CBCT. Further the Icon system 
introduces a new online patient tracking system to the 
clinical routine. The inter-fractional accuracy of patient 
positioning was controlled with a thermoplastic mask and 
CBCT. The adaptive re-planning was quick and yielded high 
quality plans. Identical dose was delivered each day because 
of adaptive re-planning. 
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Purpose or Objective: The aim of this study was to report 
the results of the validation of a previously developed 
method for dose of the day calculation in head and neck 
Tomotherapy based on deformable image registration (DIR) of 
the planning CT to MVCT taken during treatment.  
 
Material and Methods: kVCT/MVCT images of ten HN patients 
treated with Helical Tomotherapy (HT) with a simultaneous 
integrated boost (54/66/69 Gy/30 fr) were retrospectively 
analyzed. For each patient the planning kVCT (CT-plan) was 
elastically registered (DIR) to the MVCT acquired at the 15th 
therapy session (MVCT15) with a B-Spline deformation 
algorithm using Mattes mutual information (open-source 
software 3D Slicer), resulting in a deformed CT (CTdef). At 
the same day, a kVCT was acquired with the patient in the 
same treatment position (CT15) and taken as reference. 
Then, CTdef and CT15 were re-sampled to the same slice 
thickness (3mm) through linear interpolation. The original HT 
plans were recalculated both on CTdef and CT15 in the HT 
planning station using the DQA (dose quality assurance) 
module, considering the two set of images as phantoms: 
images were rigidly aligned with the CT-plan, mimicking the 
true daily repositioning. Dose distributions on CTdef and 
CT15 were compared in order to assess the reliability of the 
method; local dose differences <2% of the prescribed dose 
(DD2%) and global gamma-index values (2%-2mm; considering 
points with dose >20% of the prescribed one) were assessed 
for all the available transversal slices (step: 6 mm) with 
Mapcheck SNC Patient Software (Sun Nuclear).  
 
Results: The results of DIR was qualitatively satisfactory 
when comparing CTdef against CT15. On average, 94.4% ± 
0.9% of points passes the gamma analysis test and 87.9% ± 
1.1% of the body‘s voxel were found for DD2% (on average 27 
slices available for each patient). If excluding 3 patients 
where a relevant number of slices were cut due to the 
narrow FOV of the MVCT15, the values further improved to 
95.7% ± 0.8% and 89.1% ± 1.3% for gamma and DD2% 
respectively.  
 
 
Conclusion: CT to MVCT DIR using an open source system was 
proven to be an accurate method for calculating the dose of 
